While we find that the percentage of circulating classical or non-classical monocytes which express these M2 markers is reduced in both moderate and severe COPD, we have detected the emergence of populations of classical and non-classical M2-like monocytes with an unusually high level of CCR5 expression in patients with severe, but not moderate, COPD. Here, CCR5 is linked to chronic obstructive pulmonary disease.